V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003678 | 210010736 | 1.66 | 139.5 | Adjuvant (A) | 2014-04-17 | 2014-06-19 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100035580 |
| 210003679 | 210010737 | 1.56 | null | null | null | 2018-08-04 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101863233 |
| 210003686 | 210010740 | 1.47 | 81.8 | null | 2019-07-07 | 2019-11-17 | PERTUZUMAB + TRASTUZUMAB | null | null | PERTUZUMAB + TRASTUZUMAB | 101457830 |
| 210003690 | 210010742 | 1.66 | 113 | Adjuvant (A) | 2020-09-02 | 2020-09-02 | null | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100856400 |
| 210003691 | 210010743 | null | 57 | Neo-adjuvant (N) | 2018-12-12 | 2019-02-08 | null | 02 | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 100478792 |
| 210003693 | 210010745 | 1.69 | 74.35 | null | 2018-03-28 | 2018-06-26 | TRASTUZUMAB DERUXTECAN | 01 | null | ABEMACICLIB + FULVESTRANT | 100959064 |
| 210003697 | 210010746 | 1.71 | 72.1 | Palliative (P) | null | 2017-11-09 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100712049 |
| 210003698 | 210010747 | null | null | Adjuvant (A) | 2020-09-04 | 2020-09-04 | CARBOPLATIN + CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 02 | N | NAB-PACLITAXEL | 100105527 |
| 210003699 | 210010748 | 1.62 | 71 | Adjuvant (A) | 2019-03-21 | 2019-04-05 | null | N | N | EC | 101267281 |
| 210003704 | 210010751 | 1.53 | 65 | null | null | 2018-12-05 | Vinorelbine (oral) | N | null | VINORELBINE | 100268655 |
| 210003705 | 210010752 | 1.7 | 72.7 | null | 2019-11-07 | 2019-11-13 | Capecitabine | 02 | null | CAPECITABINE | 100776863 |
| 210003707 | 210010754 | 1.76 | 71.3 | null | 2017-01-11 | 2017-03-15 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 101126331 |
| 210003709 | 210010756 | null | null | Adjuvant (A) | null | 2019-02-04 | Paclitaxel+Trastuzumab wkly Maint | 02 | N | PACLITAXEL + TRASTUZUMAB | 101085234 |
| 210003712 | 210010758 | 1.56 | 69.3 | null | null | 2018-08-19 | null | N | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101840371 |
| 210003714 | 210010759 | 1.55 | 98.6 | Neo-adjuvant (N) | 2021-09-19 | 2021-09-21 | TCH (21 day Trastuzumab) Maint | 02 | N | CAPECITABINE | 101340915 |
| 210003715 | 210010760 | null | null | Adjuvant (A) | 2017-10-21 | 2018-03-07 | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100242146 |
| 210003716 | 210010761 | null | null | null | 2017-07-16 | 2017-07-29 | null | null | null | TRIAL UNSPECIFIED | 100856886 |
| 210003717 | 210010762 | 1.72 | 104.6 | Adjuvant (A) | null | 2017-02-28 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100417507 |
| 210003719 | 210010763 | 1.73 | 102 | Adjuvant (A) | 2019-05-13 | 2019-05-28 | Palbociclib | 02 | N | TRASTUZUMAB EMTANSINE | 101426308 |
| 210003720 | 210010764 | 1.5 | 66.7 | Palliative (P) | null | 2021-06-15 | FEC + DOCETAXEL | null | N | PACLITAXEL + TRASTUZUMAB | 101512375 |
| 210003722 | 210010766 | null | null | null | 2017-03-05 | 2017-03-17 | FEC + DOCETAXEL | null | null | FEC + DOCETAXEL | 100420307 |
| 210003724 | 210010768 | 1.55 | 103.6 | null | 2019-04-21 | 2019-05-04 | null | null | null | CARBOPLATIN | 100138044 |
| 210003729 | 210010772 | 1.96 | 70.75 | Adjuvant (A) | null | 2018-08-12 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100347717 |
| 210003733 | 210010773 | 1.74 | 81.4 | null | 2019-09-22 | 2019-09-30 | Capecitabine | null | null | CAPECITABINE | 100652022 |
| 210003735 | 210010774 | null | 120.6 | null | 2019-05-20 | 2019-05-20 | Neratinib | 02 | null | NERATINIB | 100843950 |
| 210003741 | 210010777 | 1.7 | 66 | Palliative (P) | 2018-02-01 | 2018-04-03 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100738148 |
| 210003742 | 210010778 | 1.55 | 76 | Neo-adjuvant (N) | 2020-11-23 | 2020-11-23 | PERTUZUMAB + TRASTUZUMAB | N | N | PERTUZUMAB + TRASTUZUMAB | 100243128 |
| 210003745 | 210010780 | 1.69 | 59 | Palliative (P) | 2018-03-12 | 2018-03-26 | CARBOPLATIN + DOCETAXEL + Pertuzumab + Trastuzumab | N | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101476880 |
| 210003749 | 210010783 | 1.55 | 62.4 | null | null | 2020-08-04 | Pertuzumab (Maintenance) | 02 | null | PERTUZUMAB | 101397605 |
| 210003750 | 210010784 | 1.65 | 63.5 | null | null | 2019-04-02 | Fulvestrant + Palbociclib | 02 | null | EC | 101617762 |
| 210003751 | 210010785 | 1.66 | 81.4 | null | 2018-07-29 | 2018-10-25 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101566613 |
| 210003755 | 210010788 | 1.58 | 62.5 | null | 2014-08-02 | 2016-04-01 | Carboplatin AUC 6 - 10 | null | null | CARBOPLATIN | 100206801 |
| 210003759 | 210010789 | null | null | null | 2015-12-31 | 2019-02-28 | TRASTUZUMAB EMTANSINE | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100869100 |
| 210003761 | 210010790 | 1.52 | null | null | null | 2020-05-02 | null | 02 | null | PERTUZUMAB | 100595718 |
| 210003765 | 210010793 | 1.75 | 69.65 | Neo-adjuvant (N) | null | 2017-07-11 | null | 02 | N | EPIRUBICIN | 101794773 |
| 210003767 | 210010795 | 1.68 | 78.7 | null | 2016-07-15 | 2016-07-29 | null | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100759298 |
| 210003768 | 210010796 | 1.63 | 87.7 | Palliative (P) | null | 2021-02-07 | Paclitaxel+Trastuzumab wkly Maint | N | N | PACLITAXEL + TRASTUZUMAB | 101547987 |
| 210003770 | 210010797 | 1.63 | 62.3 | Neo-adjuvant (N) | 2018-11-24 | 2018-12-20 | TCH (21 day Trastuzumab) Maint | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101804234 |
| 210003773 | 210010799 | null | null | null | 2021-11-07 | 2022-02-21 | TCH (21 day Trastuzumab) Maint | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101108908 |
| 210003777 | 210010802 | 1.61 | 84 | Palliative (P) | null | 2019-03-02 | Pertuzumab (Loading) | N | N | PERTUZUMAB | 101028848 |
| 210003782 | 210010806 | 1.53 | 77.3 | Palliative (P) | 2016-06-28 | 2017-08-02 | EC | 02 | N | TRIAL | 100450489 |
| 210003783 | 210010807 | 1.62 | 65.6 | null | 2017-05-12 | 2017-06-08 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100235204 |
| 210003791 | 210010810 | 0 | 67.1 | Curative (C) | 2020-09-24 | 2020-09-24 | GemCarbo Days 1+8 | N | N | ERIBULIN | 100632682 |
| 210003792 | 210010811 | null | null | Curative (C) | null | 2019-05-27 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100133076 |
| 210003796 | 210010813 | 1.75 | 54.8 | Palliative (P) | 2020-05-22 | 2020-05-29 | Capecitabine | 02 | N | CAPECITABINE | 100395150 |
| 210003797 | 210010814 | 1.54 | 105 | Palliative (P) | 2019-03-11 | 2019-09-21 | FEC + DOCETAXEL | 02 | N | FEC + DOCETAXEL | 100216251 |
| 210003802 | 210010816 | 1.58 | 89.6 | Adjuvant (A) | 2018-06-06 | 2018-06-28 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | RIBOCICLIB | 101468225 |
| 210003806 | 210010819 | 1.67 | 52 | Neo-adjuvant (N) | 2019-05-04 | 2019-05-19 | Paclitaxel+Trastuzumab wkly Maint | 02 | N | PACLITAXEL + TRASTUZUMAB | 101532763 |
| 210003807 | 210010820 | 1.63 | 75.2 | Palliative (P) | 2016-11-27 | 2016-12-19 | Letrozole + Palbociclib | 02 | N | PACLITAXEL + TRASTUZUMAB | 100435510 |
| 210003808 | 210010821 | 1.71 | 82 | null | 2018-10-20 | 2018-12-30 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100749803 |